GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M3 Inc (TSE:2413) » Definitions » Cyclically Adjusted Price-to-FCF

M3 (TSE:2413) Cyclically Adjusted Price-to-FCF : 35.38 (As of May. 22, 2024)


View and export this data going back to 2004. Start your Free Trial

What is M3 Cyclically Adjusted Price-to-FCF?

As of today (2024-05-22), M3's current share price is 円1581.00. M3's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was 円44.68. M3's Cyclically Adjusted Price-to-FCF for today is 35.38.

The historical rank and industry rank for M3's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSE:2413' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.11   Med: 154.69   Max: 498.82
Current: 36.11

During the past years, M3's highest Cyclically Adjusted Price-to-FCF was 498.82. The lowest was 36.11. And the median was 154.69.

TSE:2413's Cyclically Adjusted Price-to-FCF is ranked worse than
62.13% of 169 companies
in the Healthcare Providers & Services industry
Industry Median: 23.87 vs TSE:2413: 36.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

M3's adjusted free cash flow per share data for the three months ended in Mar. 2024 was 円33.269. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is 円44.68 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


M3 Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for M3's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M3 Cyclically Adjusted Price-to-FCF Chart

M3 Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.07 321.35 147.75 87.74 47.96

M3 Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.74 79.51 66.32 55.70 47.96

Competitive Comparison of M3's Cyclically Adjusted Price-to-FCF

For the Health Information Services subindustry, M3's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M3's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M3's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where M3's Cyclically Adjusted Price-to-FCF falls into.



M3 Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

M3's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=1581.00/44.68
=35.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, M3's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=33.269/107.2000*107.2000
=33.269

Current CPI (Mar. 2024) = 107.2000.

M3 Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 1.213 98.000 1.327
201409 3.952 98.500 4.301
201412 1.749 97.900 1.915
201503 6.340 97.900 6.942
201506 0.653 98.400 0.711
201509 5.591 98.500 6.085
201512 2.260 98.100 2.470
201603 9.075 97.900 9.937
201606 3.036 98.100 3.318
201609 6.973 98.000 7.628
201612 2.801 98.400 3.051
201703 11.545 98.100 12.616
201706 4.406 98.500 4.795
201709 7.178 98.800 7.788
201712 -0.326 99.400 -0.352
201803 10.445 99.200 11.287
201806 4.147 99.200 4.481
201809 8.296 99.900 8.902
201812 -4.057 99.700 -4.362
201903 16.919 99.700 18.192
201906 6.199 99.800 6.659
201909 7.990 100.100 8.557
201912 4.809 100.500 5.130
202003 16.288 100.300 17.409
202006 9.812 99.900 10.529
202009 15.658 99.900 16.802
202012 14.500 99.300 15.654
202103 25.738 99.900 27.619
202106 11.124 99.500 11.985
202109 14.163 100.100 15.168
202112 16.945 100.100 18.147
202203 29.735 101.100 31.529
202206 12.117 101.800 12.760
202209 21.589 103.100 22.448
202212 9.848 104.100 10.141
202303 29.366 104.400 30.154
202306 12.686 105.200 12.927
202309 18.863 106.200 19.041
202312 9.847 106.800 9.884
202403 33.269 107.200 33.269

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


M3  (TSE:2413) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


M3 Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of M3's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


M3 (TSE:2413) Business Description

Traded in Other Exchanges
Address
Akasaka Intercity 10th floor, 1-11-44 Akasaka, Minato-ku, Tokyo, JPN, 105-0012
M3, Inc. is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.

M3 (TSE:2413) Headlines

No Headlines